Previous close | 54.20 |
Open | 54.20 |
Bid | 39.60 |
Ask | 42.70 |
Strike | 210.00 |
Expiry date | 2024-12-20 |
Day's range | 54.20 - 54.20 |
Contract range | N/A |
Volume | |
Open interest | 5 |
The medical devices and novel treatments United Therapeutics Corporation (UTHR) develops to treat pulmonary arterial hypertension (PAH) and other ailments are attracting substantial Big Money investment.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., June 27, 2024--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced the addition of former Minnesota Commissioner of Health Jan Malcolm to its Board of Directors. Ms. Malcolm was elected by the company’s shareholders at its annual meeting held on June 26, 2024.